Authors:
SEIBOLD JR
CLEMENTS PJ
FURST DE
MAYES MD
MCCLOSKEY DA
MORELAND LW
WHITE B
WIGLEY FM
ROCCO S
ERIKSON M
HANNIGAN JF
SANDERS ME
AMENTO EP
Citation: Jr. Seibold et al., SAFETY AND PHARMACOKINETICS OF RECOMBINANT HUMAN RELAXIN IN SYSTEMIC-SCLEROSIS, Journal of rheumatology, 25(2), 1998, pp. 302-307
Authors:
FURST DE
CLEMENTS PJ
STEEN VD
MEDSGER TA
MASI AT
DANGELO WA
LACHENBRUCH PA
GRAU RG
SEIBOLD JR
Citation: De. Furst et al., THE MODIFIED RODNAN SKIN SCORE IS AN ACCURATE REFLECTION OF SKIN BIOPSY THICKNESS IN SYSTEMIC-SCLEROSIS, Journal of rheumatology, 25(1), 1998, pp. 84-88
Authors:
WIGLEY FM
KORN JH
CSUKA ME
MEDSGER TA
ROTHFIELD NF
ELLMAN M
MARTIN R
COLLIER DH
WEINSTEIN A
FURST DE
JIMENEZ SA
MAYES MD
MERKEL PA
GRUBER B
KAUFMAN L
VARGA J
BELL P
KERN J
MARROTT P
WHITE B
SIMMS RW
PHILLIPS AC
SEIBOLD JR
Citation: Fm. Wigley et al., ORAL ILOPROST TREATMENT IN PATIENTS WITH RAYNAUDS-PHENOMENON SECONDARY TO SYSTEMIC-SCLEROSIS - A MULTICENTER, PLACEBO-CONTROLLED DOUBLE-BLIND STUDY, Arthritis and rheumatism, 41(4), 1998, pp. 670-677
Authors:
STURGILL MG
GRASING KW
ROSEN RC
THOMAS TJ
KULKARNI GD
TROUT JR
MAINES M
SEIBOLD JR
Citation: Mg. Sturgill et al., YOHIMBINE ELIMINATION IN NORMAL VOLUNTEERS IS CHARACTERIZED BY BOTH ONE-COMPARTMENT AND 2-COMPARTMENT BEHAVIOR, Journal of cardiovascular pharmacology, 29(6), 1997, pp. 697-703
Authors:
SALAZAR DE
MUCH DR
NICHOLA PS
SEIBOLD JR
SHINDLER D
SLUGG PH
Citation: De. Salazar et al., A PHARMACOKINETIC-PHARMACODYNAMIC MODEL OF D-SOTALOL Q-TC PROLONGATION DURING INTRAVENOUS ADMINISTRATION TO HEALTHY-SUBJECTS, Journal of clinical pharmacology, 37(9), 1997, pp. 799-809
Authors:
KIRK SE
GERTZ BJ
SCHNEIDER SH
HARTMAN ML
PEZZOLI SS
WITTREICH JM
KRUPA DA
SEIBOLD JR
THORNER MO
Citation: Se. Kirk et al., EFFECT OF OBESITY AND FEEDING ON THE GROWTH-HORMONE (GH) RESPONSE TO THE GH SECRETAGOGUE L-692,429 IN YOUNG MEN, The Journal of clinical endocrinology and metabolism, 82(4), 1997, pp. 1154-1159
Authors:
SEIBOLD JR
KORN J
SIMMS R
CLEMENTS PJ
MORELAND L
MAYES MD
FURST DE
ROTHFIELD N
STEEN V
WEISMAN M
DEMARCO P
COLLIER D
WIGLEY F
MERKEL PA
CSUKA ME
ROCCO S
ERIKSON M
HANNIGAN J
HARKONEN WS
SANDERS ME
Citation: Jr. Seibold et al., CONTROLLED TRIAL OF RECOMBINANT HUMAN RELAXIN (RHRLXN) IN DIFFUSE SCLERODERMA (DS), Arthritis and rheumatism, 40(9), 1997, pp. 557-557
Authors:
CLEMENTS PJ
WONG WK
SEIBOLD JR
FURST DE
MAYES M
WHITE B
WIGLEY F
WEISMAN M
BARR W
WEINSTEIN A
MEDSGER T
STEEN V
MARTIN R
MORELAND L
COLLIER D
LALLY E
VARGA J
ANDREWS B
WEINER S
ABELES M
Citation: Pj. Clements et al., HIGH-DOSE (HI-DPA) VS LOW-DOSE (LO-DPA) PENICILLAMINE IN EARLY DIFFUSE SYSTEMIC-SCLEROSIS (SSC) TRIAL - ANALYSIS OF TRIAL, Arthritis and rheumatism, 40(9), 1997, pp. 854-854
Authors:
GRASING K
STURGILL MG
ROSEN RC
TROUT JR
THOMAS TJ
KULKARNI GD
MAINES P
SEIBOLD JR
Citation: K. Grasing et al., EFFECTS OF YOHIMBINE ON AUTONOMIC MEASURES ARE DETERMINED BY INDIVIDUAL-VALUES FOR AREA UNDER THE CONCENTRATION-TIME CURVE, Journal of clinical pharmacology, 36(9), 1996, pp. 814-822
Authors:
GRASING K
MURPHY MG
LIN JI
SWIGAR M
FREEDHOLM D
CLARKE L
ZHANG J
WOLKOWITZ OM
WEINGARTNER H
PUTNAM K
SEIBOLD JR
Citation: K. Grasing et al., HUMAN PHARMACOKINETICS AND TOLERABILITY OF L-365,260, A NOVEL CHOLECYSTOKININ-B ANTAGONIST, Journal of clinical pharmacology, 36(4), 1996, pp. 292-300
Authors:
GRASING K
FREEDHOLM D
MURPHY MG
SWIGAR M
RUSSER T
NOSHER J
LIN J
FRAME V
CLARKE L
SEIBOLD JR
Citation: K. Grasing et al., SELECTIVE BLOCKADE OF CHOLECYSTOKININ TYPE-B RECEPTORS WITH L-365,260DOES NOT IMPAIR GALLBLADDER CONTRACTION IN NORMAL HUMANS, The American journal of gastroenterology, 91(3), 1996, pp. 569-573
Citation: Tj. Thomas et al., DEFECTIVE SIGNAL-TRANSDUCTION PATHWAYS IN T-CELLS FROM AUTOIMMUNE MRL-LPR LPR MICE ARE ASSOCIATED WITH INCREASED POLYAMINE CONCENTRATIONS/, Biochemical journal, 311, 1995, pp. 175-182
Citation: Tj. Thomas et al., TRIPLEX-DNA STABILIZATION BY HYDRALAZINE AND THE PRESENCE OF ANTI-(TRIPLEX DNA) ANTIBODIES IN PATIENTS TREATED WITH HYDRALAZINE, Biochemical journal, 311, 1995, pp. 183-188
Authors:
HUHN RD
OCONNELL SM
RADWANSKI E
CUTLER DL
STURGILL M
CLARKE L
SEIBOLD JR
Citation: Rd. Huhn et al., PHASE-I PHARMACODYNAMIC STUDY OF INTRAVENOUS (IV) RECOMBINANT HUMAN INTERLEUKIN-10 (RHIL-10) IN NORMAL VOLUNTEERS, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 162-162
Authors:
HUHN RD
YURKOW EJ
KUHN JG
CLARKE L
GUNN H
RESTA D
SHAH R
MYERS LA
SEIBOLD JR
Citation: Rd. Huhn et al., PHARMACODYNAMICS OF DAILY SUBCUTANEOUS RECOMBINANT HUMAN INTERLEUKIN-3 IN NORMAL VOLUNTEERS, Clinical pharmacology and therapeutics, 57(1), 1995, pp. 32-41
Authors:
FURST DE
SEIBOLD JR
STEEN VD
MEDSGER TA
MASI AT
DANGELO WA
LACHENBRUCH PA
CLEMENTS PJ
Citation: De. Furst et al., THE MODIFIED RODNAN SKIN SCORE (SKSC) IS AN ACCURATE REFLECTION OF SKIN THICKNESS IN SYSTEMIC-SCLEROSIS (SSC), Arthritis and rheumatism, 38(9), 1995, pp. 1088-1088
Authors:
CLEMENTS P
LACHENBRUCH PA
SEIBOLD JR
STEEN VD
MEDSGER TA
MASI A
FURST DE
Citation: P. Clements et al., KETANSERIN (KTN) VS PLACEBO (PLAC) IN SYSTEMIC-SCLEROSIS (SSC) TRIAL - PREDICTORS OF LONG-TERM SURVIVAL, Arthritis and rheumatism, 38(9), 1995, pp. 1089-1089
Citation: Pj. Clements et al., HIGH-DOSE (HI-CPA) VS LOW-DOSE (LO-DPA) PENICILLAMINE IN EARLY DIFFUSE SYSTEMIC-SCLEROSIS (SSC) TRIAL - A PROGRESS REPORT, Arthritis and rheumatism, 38(9), 1995, pp. 1090-1090
Citation: Hc. Hsu et al., REGULATION OF ORNITHINE DECARBOXYLASE IN THE KIDNEY OF AUTOIMMUNE MICE WITH THE LPR GENE, Autoimmunity, 19(4), 1994, pp. 253-264
Authors:
CLEGG DO
READING JC
MAYES MD
SEIBOLD JR
HARRIS C
WIGLEY FM
WARD JR
PISKO EJ
WEISMAN MH
LEE P
MORELAND LW
NEUNER R
GALL E
CLEMENTS P
SPINDLER J
LALLY EV
Citation: Do. Clegg et al., COMPARISON OF AMINOBENZOATE POTASSIUM AND PLACEBO IN THE TREATMENT OFSCLERODERMA, Journal of rheumatology, 21(1), 1994, pp. 105-110
Authors:
CHENG HY
SCHWARTZ JI
LIN C
AMIN RD
SEIBOLD JR
LASSETER KC
EBEL DL
TOCCO DJ
ROGERS JD
Citation: Hy. Cheng et al., THE BIOAVAILABILITY AND NONLINEAR PHARMACOKINETICS OF MK-679 IN HUMANS, Biopharmaceutics & drug disposition, 15(5), 1994, pp. 409-418